{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:07:14Z","timestamp":1791522434271,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pathological cardiac hypertrophy is the main predecessor of heart failure. Its pathology is sophisticated, and its progression is associated with multiple cellular processes. To explore new therapeutic approaches, more precise examination of cardiomyocyte subtypes and involved biological processes is required in response to hypertrophic stimuli. Mitochondria and the endoplasmic reticulum (ER) are two crucial organelles associated with the progression of cardiac hypertrophy and are connected through junctions known as mitochondria-associated endoplasmic reticulum membranes (MAMs). Although MAM genes are altered in cardiac hypertrophy, the importance of MAMs in cardiac hypertrophy and the expression pattern of MAMs in certain cardiac cell types require a comprehensive analysis. In this study, we analyzed the temporal expression of MAM proteins in the process of cardiac hypertrophy and observed that MAM-related proteins preferentially accumulated in cardiomyocytes at the initial stage of cardiac hypertrophy and underwent a gradual decline, which was synchronized with the proportion of two cardiomyocyte subtypes (CM2 and CM3). Meanwhile, these subtypes went through a functional switch during cardiac hypertrophy. Trajectory analysis suggested that there was a differentiation trajectory of cardiomyocyte subtypes from high to low MAM protein expression. Distinct regulon modules across different cardiomyocyte cell types were revealed by transcriptional regulatory network analysis. Furthermore, scWGCNA revealed that MAM-related genes were clustered into a module that correlated with diabetic cardiomyopathy. Altogether, we identified cardiomyocyte subtype transformation and the potential critical transcription factors involved, which may serve as therapeutic targets in combating cardiac hypertrophy.<\/jats:p>","DOI":"10.1038\/s41598-023-35464-2","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T11:04:31Z","timestamp":1684839871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Single-cell transcriptional profiling of hearts during cardiac hypertrophy reveals the role of MAMs in cardiomyocyte subtype switching"],"prefix":"10.1038","volume":"13","author":[{"given":"Yi","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"1","key":"35464_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12951-022-01630-3","volume":"20","author":"L Mao","year":"2022","unstructured":"Mao, L. et al. Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy. J. Nanobiotechnol. 20(1), 435 (2022).","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"35464_CR2","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.biocel.2005.04.011","volume":"37","author":"EA Woodcock","year":"2005","unstructured":"Woodcock, E. A. & Matkovich, S. J. Cardiomyocytes structure, function and associated pathologies. Int. J. Biochem. Cell Biol. 37(9), 1746\u20131751 (2005).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"35464_CR3","doi-asserted-by":"publisher","first-page":"175262","DOI":"10.1016\/j.ejphar.2022.175262","volume":"933","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension. Eur. J. Pharmacol. 933, 175262 (2022).","journal-title":"Eur. J. Pharmacol."},{"issue":"Pt 1","key":"35464_CR4","doi-asserted-by":"publisher","first-page":"136576","DOI":"10.1016\/j.chemosphere.2022.136576","volume":"309","author":"S Ji","year":"2022","unstructured":"Ji, S. et al. NO2 exposure contributes to cardiac hypertrophy in male mice through apoptosis signaling pathways. Chemosphere 309(Pt 1), 136576 (2022).","journal-title":"Chemosphere"},{"issue":"10","key":"35464_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41419-022-05231-8","volume":"13","author":"LL Yang","year":"2022","unstructured":"Yang, L. L. et al. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING. Cell Death Dis. 13(10), 889 (2022).","journal-title":"Cell Death Dis."},{"key":"35464_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijcard.2022.09.070","volume":"371","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. IRX2 activated by jumonji domain-containing protein 2A is crucial for cardiac hypertrophy and dysfunction in response to the hypertrophic stimuli. Int. J. Cardiol. 371, 332\u2013344 (2022).","journal-title":"Int. J. Cardiol."},{"key":"35464_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-3-319-55330-6_11","volume":"982","author":"H Facundo","year":"2017","unstructured":"Facundo, H. et al. Mitochondria and cardiac hypertrophy. Adv. Exp. Med. Biol. 982, 203\u2013226 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"35464_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yjmcc.2012.09.002","volume":"55","author":"MG Rosca","year":"2013","unstructured":"Rosca, M. G., Tandler, B. & Hoppel, C. L. Mitochondria in cardiac hypertrophy and heart failure. J. Mol. Cell Cardiol. 55, 31\u201341 (2013).","journal-title":"J. Mol. Cell Cardiol."},{"issue":"9","key":"35464_CR9","first-page":"586","volume":"70","author":"X Liang","year":"2015","unstructured":"Liang, X. et al. Characterization of endonuclease G and mitochondria-sarcoplasmic reticulum-related proteins during cardiac hypertrophy. Pharmazie 70(9), 586\u2013592 (2015).","journal-title":"Pharmazie"},{"key":"35464_CR10","doi-asserted-by":"publisher","first-page":"112890","DOI":"10.1016\/j.biopha.2022.112890","volume":"149","author":"J Liu","year":"2022","unstructured":"Liu, J. & Yang, J. Mitochondria-associated membranes: A hub for neurodegenerative diseases. Biomed. Pharmacother. 149, 112890 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"35464_CR11","doi-asserted-by":"publisher","first-page":"604240","DOI":"10.3389\/fcell.2020.604240","volume":"8","author":"P Gao","year":"2020","unstructured":"Gao, P., Yan, Z. & Zhu, Z. Mitochondria-associated endoplasmic reticulum membranes in cardiovascular diseases. Front. Cell Dev. Biol. 8, 604240 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"35464_CR12","doi-asserted-by":"publisher","first-page":"4578809","DOI":"10.1155\/2021\/4578809","volume":"2021","author":"Y Luan","year":"2021","unstructured":"Luan, Y. et al. Structure and function of mitochondria-associated endoplasmic reticulum membranes (MAMs) and their role in cardiovascular diseases. Oxid. Med. Cell Longev. 2021, 4578809 (2021).","journal-title":"Oxid. Med. Cell Longev."},{"key":"35464_CR13","doi-asserted-by":"publisher","first-page":"959844","DOI":"10.3389\/fmolb.2022.959844","volume":"9","author":"B Nieblas","year":"2022","unstructured":"Nieblas, B., Perez-Trevino, P. & Garcia, N. Role of mitochondria-associated endoplasmic reticulum membranes in insulin sensitivity, energy metabolism, and contraction of skeletal muscle. Front. Mol. Biosci. 9, 959844 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"35464_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.abb.2018.12.018","volume":"662","author":"S Wu","year":"2019","unstructured":"Wu, S. & Zou, M. H. Mitochondria-associated endoplasmic reticulum membranes in the heart. Arch. Biochem. Biophys. 662, 201\u2013212 (2019).","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"35464_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/FJC.0000000000001301","volume":"80","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Transient receptor potential vanilloid type 1 protects against pressure overload-induced cardiac hypertrophy by promoting mitochondria-associated endoplasmic reticulum membranes. J. Cardiovasc. Pharmacol. 80(3), 430\u2013441 (2022).","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"8","key":"35464_CR16","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.114.300569","volume":"114","author":"SR Houser","year":"2014","unstructured":"Houser, S. R. Role of RyR2 phosphorylation in heart failure and arrhythmias: protein kinase A-mediated hyperphosphorylation of the ryanodine receptor at serine 2808 does not alter cardiac contractility or cause heart failure and arrhythmias. Circ. Res. 114(8), 1320\u201313207 (2014).","journal-title":"Circ. Res."},{"issue":"3","key":"35464_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41419-018-0416-1","volume":"9","author":"J Rieusset","year":"2018","unstructured":"Rieusset, J. The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis: an update. Cell Death Dis. 9(3), 388 (2018).","journal-title":"Cell Death Dis."},{"key":"35464_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"issue":"1","key":"35464_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"35464_CR20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"35464_CR21","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"35464_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/HYPERTENSIONAHA.109.130351","volume":"54","author":"D Graham","year":"2009","unstructured":"Graham, D. et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54(2), 322\u2013328 (2009).","journal-title":"Hypertension"},{"issue":"8","key":"35464_CR23","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1074\/jbc.M805768200","volume":"284","author":"SJ Stone","year":"2009","unstructured":"Stone, S. J. et al. The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J. Biol. Chem. 284(8), 5352\u20135361 (2009).","journal-title":"J. Biol. Chem."},{"issue":"23","key":"35464_CR24","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1161\/CIRCULATIONAHA.117.030235","volume":"136","author":"S Wu","year":"2017","unstructured":"Wu, S. et al. Binding of FUN14 domain containing 1 with inositol 1,4,5-trisphosphate receptor in mitochondria-associated endoplasmic reticulum membranes maintains mitochondrial dynamics and function in hearts in vivo. Circulation 136(23), 2248\u20132266 (2017).","journal-title":"Circulation"},{"issue":"23","key":"35464_CR25","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.lfs.2007.04.003","volume":"80","author":"L Fang","year":"2007","unstructured":"Fang, L. et al. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci. 80(23), 2154\u20132160 (2007).","journal-title":"Life Sci."},{"issue":"2","key":"35464_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1074248410385683","volume":"16","author":"H Yu","year":"2011","unstructured":"Yu, H. et al. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy. J. Cardiovasc. Pharmacol. Ther. 16(2), 205\u2013211 (2011).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"13","key":"35464_CR27","doi-asserted-by":"publisher","first-page":"253443","DOI":"10.1242\/jcs.253443","volume":"134","author":"S Han","year":"2021","unstructured":"Han, S. et al. The role of Mfn2 in the structure and function of endoplasmic reticulum-mitochondrial tethering in vivo. J. Cell Sci. 134(13), 253443 (2021).","journal-title":"J. Cell Sci."},{"issue":"11","key":"35464_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1517\/14728220903264064","volume":"13","author":"MS Bhuiyan","year":"2009","unstructured":"Bhuiyan, M. S. & Fukunaga, K. Stimulation of sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats. Expert Opin. Ther. Targets 13(11), 1253\u20131265 (2009).","journal-title":"Expert Opin. Ther. Targets"},{"key":"35464_CR29","doi-asserted-by":"publisher","first-page":"e2238","DOI":"10.1038\/cddis.2016.139","volume":"7","author":"AR Hall","year":"2016","unstructured":"Hall, A. R. et al. Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction. Cell Death Dis. 7, e2238 (2016).","journal-title":"Cell Death Dis."},{"key":"35464_CR30","doi-asserted-by":"publisher","first-page":"102289","DOI":"10.1016\/j.redox.2022.102289","volume":"52","author":"M Yuan","year":"2022","unstructured":"Yuan, M. et al. IP3R1\/GRP75\/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling. Redox Biol. 52, 102289 (2022).","journal-title":"Redox Biol."},{"issue":"1","key":"35464_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/CIRCRESAHA.117.305349","volume":"117","author":"T Kamo","year":"2015","unstructured":"Kamo, T., Akazawa, H. & Komuro, I. Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ. Res. 117(1), 89\u201398 (2015).","journal-title":"Circ. Res."},{"issue":"2","key":"35464_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/CIRCRESAHA.116.305547","volume":"116","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ. Res. 116(2), 237\u2013244 (2015).","journal-title":"Circ. Res."},{"issue":"2","key":"35464_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvq376","volume":"90","author":"A Planavila","year":"2011","unstructured":"Planavila, A. et al. Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc. Res. 90(2), 276\u2013284 (2011).","journal-title":"Cardiovasc. Res."},{"key":"35464_CR34","unstructured":"Miao, J., et al., Effects of ZFP580 on Ventricular Remodeling after Myocardial Ischemia\/reperfusion in Rats. 33(3), 262\u2013266 (2017)."},{"issue":"1","key":"35464_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H. et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 27(1), 29\u201334 (1999).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35464-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T11:08:01Z","timestamp":1684840081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35464-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35464"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35464-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8339"}}